Get the content you want anytime you want.

The Contagion® Healthcare Associated Infections (HAI) specialty page provides HAI-specific clinical news and articles, coverage from conferences and meetings, links to condition-specific resources, and videos and other content.


Bezlotoxumab Treatment Reduced <i>C diff</i> Recurrence in Cancer Patients, Study Reports
Treatment with bezlotoxumab resulted in a statistically significant reduction of recurrent C diff in cancer patients, according to a new study.
Asymptomatic <i>C diff</i> Carriers Prevalent Among Admitted Hospital Patients
Some asymptomatic carriers of C diff went on to have clinical infection themselves within a 6-month period.
Earlier Initiation of Daptomycin-Ceftaroline for MRSA Bacteremia May Improve Outcomes
Earlier initiation of DAP-CPT combination therapy may be beneficial, despite a tendency to use the therapy after initial treatment failure. 
Why Have Efforts to Vaccinate Against <i>S aureus</i> Failed?
A new study published in the Journal of Clinical Investigation may offer some insight on why past efforts to develop a vaccine for S aureus have failed.
Health Care Workers Often Work Despite Illness
Even as hospitals try to stop health care-associated illnesses, they can often have difficulty identifying which employees are too sick to work. New research suggests a high number of health care employees work while experiencing symptoms of illness.
Developing a Risk Prediction Model for Health Care-Associated <i>C Diff</i> Infection
A team of investigators set out to identify whether a risk prediction model that was developed at Novant Health could accurately identify individuals at a high-risk for health care-associated C diff infection.
Fidaxomicin Well-Tolerated in Pediatric <i>C diff</i> Cases
Prior to this study’s publication, the literature about pediatric C diff infection was limited.
Get Off the SOFA! Introducing the Quick Pitt Bacteremia Score
The quick Pitt Bacteremia Score offers accuracy comparable to the original version's across multiple infections, and maintains ease of use.
Is there a cure? How long until we find it? And will it work for the majority of people living with HIV?